Skip to main content
. Author manuscript; available in PMC: 2013 Dec 15.
Published in final edited form as: Clin Cancer Res. 2012 Oct 2;18(24):6758–6770. doi: 10.1158/1078-0432.CCR-12-1177

Fig. 3. Comparison of total cells infused and major T-cell subsets in the infused TIL product between responders and non-responders.

Fig. 3

Comparison of total TIL infused (A), the percentage and total number of infused CD8+ T cells (B), and the percentage and total number of CD4+ T cells (C) between responders and non-responders. Linear regression showing the relationship between total CD8+ infused and percentage change in tumor burden (p=0.0003), with the solid line in showing the best fit, the broken line representing the 95% prediction limits, and the grey area indicating the 95% confidence limits (D).